The interaction between pDCs (BDCA2) and MM cells (CD138) increases the production of cytokines and chemokines, which can not only prolong the survival of pDCs but also confer growth, survival, and drug resistance in MM cells (59). This evidence concerns the gene CLEC4C and Miyoshi myopathy.